{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T20:42:24Z","timestamp":1786653744482,"version":"build-2736575974"},"reference-count":12,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>Serous borderline tumors (SBT) are defined by the World Health Organization (WHO) as serous neoplasms that show epithelial proliferation greater than that seen in serous cystadenomas, as evidenced by cellular stratification, cytologic atypicality, and epithelial tufting, but which exhibit no evidence of \"destructive stromal\" invasion and can show extra-ovarian implants. Characterization of invasive peritoneal implants from patients with noninvasive serous ovarian tumors has important prognostic and treatment implications. Peritoneal implants have been classified as either noninvasive or invasive based on their histopathologic appearance. Three criteria were applied for the diagnosis of \"invasive\" implants: Invasion of underlying normal tissue, micropapillary architecture, and solid epithelial nests surrounded by clefts. We encountered two cases of unilateral ovarian serous borderline tumors with non-invasive peritoneal implants in a 43-year-old female, and invasive peritoneal implants in 76-year-old female.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/0973-1482.147707","type":"journal-article","created":{"date-parts":[[2015,10,9]],"date-time":"2015-10-09T11:54:49Z","timestamp":1444391689000},"page":"646","source":"Crossref","is-referenced-by-count":6,"title":["Ovarian serous borderline tumors with noninvasive and invasive peritoneal implants"],"prefix":"10.4103","volume":"11","author":[{"given":"Banushree C.","family":"Srinivasamurthy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ambedkar Raj Kulandai","family":"Velu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nagarajan","family":"Krishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anand Shankar Rao","family":"Patil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-30-20231126","first-page":"204","article-title":"Malignant and semi-malignant tumors of the ovary","volume":"48","author":"Taylor","year":"1929","journal-title":"Surg Gynecol Obstet"},{"key":"R2-30-20231126","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1002\/1097-0142(19930301)71:5<1810::AID-CNCR2820710516>3.0.CO;2-V","article-title":"A retrospective study of 370 borderline tumors of the ovary treated at the Norwegian Radium Hospital from 1970 to 1982. A review of clinicopathologic features and treatment modalities","volume":"71","author":"Kaern","year":"1993","journal-title":"Cancer"},{"key":"R3-30-20231126","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1002\/1097-0142(19881115)62:10<2212::AID-CNCR2820621024>3.0.CO;2-W","article-title":"Peritoneal implants of ovary serous borderline tumors: Histologic features and prognosis","volume":"62","author":"Bell","year":"1988","journal-title":"Cancer"},{"key":"R4-30-20231126","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/(SICI)1097-0142(19960715)78:2<278::AID-CNCR14>3.0.CO;2-T","article-title":"Ovarian papillary serous tumors of low malignant potential (serous borderline tumors). A long term follow-up study, including patients with microinvasion, lymph node metastasis, and transformation to invasive serous carcinoma","volume":"78","author":"Kennedy","year":"1996","journal-title":"Cancer"},{"key":"R5-30-20231126","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1097\/00000478-199206000-00005","article-title":"Ovarian serous tumors of low malignant potential (serous borderline tumors). The relationship of exophytic surface tumor to peritoneal \"implants\"","volume":"16","author":"Segal","year":"1992","journal-title":"Am J Surg Pathol"},{"key":"R6-30-20231126","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1016\/S0893-3952(22)04457-X","article-title":"Borderline epithelial tumours of ovary","volume":"18","author":"Hart","year":"2005","journal-title":"Mod Pathol"},{"key":"R7-30-20231126","first-page":"213A","article-title":"Autoimplants involving serous borderline tumors of the ovary: A clinicopathologic study of 30 cases","volume":"17","author":"Rollins","year":"2004","journal-title":"Mod Pathol"},{"key":"R8-30-20231126","doi-asserted-by":"crossref","first-page":"330","DOI":"10.2214\/AJR.09.3936","article-title":"Current update on borderline ovarian neoplasms","volume":"194","author":"Lalwani","year":"2010","journal-title":"AJR Am J Roentgenol"},{"key":"R9-30-20231126","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1097\/01.pas.0000213294.81154.95","article-title":"The recurrence and the overall survival rates of ovarian serous borderline neoplasms with non-invasive implants is time dependent","volume":"30","author":"Silva","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"R10-30-20231126","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ygyno.2007.01.054","article-title":"Microinvasion links ovarian serous borderline tumor and grade 1 invasive carcinoma","volume":"106","author":"Hogg","year":"2007","journal-title":"Gynaecol Oncol"},{"key":"R11-30-20231126","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/01.LAB.0000056994.81259.32","article-title":"K-RAS mutations in ovarian and extraovarian lesions of serous tumors of borderline malignancy","volume":"83","author":"Diebold","year":"2003","journal-title":"Lab Invest"},{"key":"R12-30-20231126","doi-asserted-by":"crossref","first-page":"e103","DOI":"10.1016\/S1470-2045(11)70288-1","article-title":"Borderline ovarian tumour: Pathological diagnostic dilemma and risk factors for invasive or lethal recurrence","volume":"13","author":"Morice","year":"2012","journal-title":"Lancet Oncol"}],"container-title":["Journal of Cancer Research and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01363817-201511030-00030","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:41:41Z","timestamp":1786650101000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01363817-201511030-00030"}},"subtitle":["A case report each"],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":12,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.4103\/0973-1482.147707","relation":{},"ISSN":["0973-1482"],"issn-type":[{"value":"0973-1482","type":"print"}],"subject":[],"published":{"date-parts":[[2015]]}}}